Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells

British Journal of Pharmacology

Volumn 141, Issue 3, 2004, Pages 477-487

  Valatas, Vassilis ^a   Kolios, George ^a   Manousou, Pinelopi ^a   Notas, George ^a   Xidakis, Costas ^a   Diamantis, Ioannis ^a   Kouroumalis, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Chemokine(s); Kupffer cell(s); Liver; Neuropeptide(s); Octreotide; Sinusoidal cell(s); Somatostatin

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; OCTREOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RANTES; SOMATOSTATIN DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOREGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT;

ANIMALS; CELLS, CULTURED; CHEMOKINES, CC; CHEMOKINES, CXC; DOSE-RESPONSE RELATIONSHIP, DRUG; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MALE; OCTREOTIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 1542299761     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705633     Document Type: Article

References (65)

1. AJUEBOR, M.N. & SWAIN, M.G. (2002). Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology, 105, 137-143.
2. ANDOH, A., HATA, K., SHIMADA, M., FUJINO, S., TASAKI, K., BAMBA, S., ARAKI, Y., FUJIYAMA, Y. & BAMBA, T. (2002). Inhibitory effects of somatostatin on tumor necrosis factor-alpha-induced interleukin-6 secretion in human pancreatic periacinar myofibroblasts. Int. J. Mol. Med., 10, 89-93.
3. BAYON, L.G., IZQUIERDO, M.A., SIROVICH, I., VAN ROOIJEN, N., BEELEN, R.H. & MEIJER, S. (1996). Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology, 23, 1224-1231.
4. BONE-LARSON, C.L., SIMPSON, K.J., COLLETTI, L.M., LUKACS, N.W., CHEN, S.C., LIRA, S., KUNKEL, S.L. & HOGABOAM, C.M. (2000). The role of chemokines in the immunopathology of the liver. Immunol. Rev., 177, 8-20.
5. BUKARA, M. & BAUTISTA, A.P. (2000). Acute alcohol intoxication and gadolinium chloride attenuate endotoxin-induced release of CC chemokines in the rat. Alcohol, 20, 193-203.
6. CARRUTHERS, A.M., WARNER, A.J., MICHEL, A.D., FENIUK, W. & HUMPHREY, P.P. (1999). Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins. Br. J. Pharmacol., 126, 1221-1229.
7. CHAO, T.C., CHAO, H.H., LIN, J.D. & CHEN, M.F. (1999). Somatostatin and octreotide modulate the function of Kupffer cells in liver cirrhosis. Regul. Pept., 79, 117-124.
8. CHOWERS, Y., CAHALON, L., LAHAV, M., SCHOR, H., TAL, R., BAR-MEIR, S. & LEVITE, M. (2000). Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha-and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. J. Immunol., 165, 2955-2961.
9. DAMBACH, D.M., WATSON, L.M., GRAY, K.R., DURHAM, S.K. & LASKIN, D.L. (2002). Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology, 35, 1093-1103.
10. DE JONG, M., BREEMAN, W.A., BERNARD, B.F., VAN GAMEREN, A., DE BRUIN, E., BAKKER, W.H., VAN DER PLUIJM, M.E., VISSER, T.J., MACKE, H.R. & KRENNING, E.P. (1999). Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. Eur. J. Nucl. Med., 26, 693-698.
11. EL SALHY, M., STENLING, R. & GRIMELIUS, L. (1993). Peptidergic innervation and endocrine cells in the human liver. Scand. J. Gastroenterol., 28, 809-815.
12. FAUSTO, N., LAIRD, A.D. & WEBBER, E.M. (1995). Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J., 9, 1527-1536.
13. FENTON, M.J. & GOLENBOCK, D.T. (1998). LPS-binding proteins and receptors. J. Leukoc. Biol., 64, 25-32.
14. FORT, J., OBERTI, F., PILETTE, C., VEAL, N., GALLOIS, Y., DOUAY, O., ROUSSELET, M.C., ROSENBAUM, J. & CALES, P. (1998). Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology, 28, 1525-1531.
15. GUHA, M. & MACKMAN, N. (2002). The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem., 277, 32124-32132.
16. JORDAN, N.J., KOLIOS, G., ABBOT, S.E., SINAI, M.A., THOMPSON, D.A., PETRAKI, K. & WESTWICK, J. (1999). Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest., 104, 1061-1069.
17. JORDAN, N.J., WATSON, M.L., YOSHIMURA, T. & WESTWICK, J. (1996). Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts. Br. J. Pharmacol., 117, 1245-1253.
18. KARALIS, K., MASTORAKOS, G., CHROUSOS, G.P. & TOLIS, G. (1994). Somatostatin analogues suppress the inflammatory reaction in vivo. J. Clin. Invest., 93, 2000-2006.
19. KIM, J.M., KIM, J.S., JUN, H.C., OH, Y.K., SONG, I.S. & KIM, C.Y. (2002). Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A. Microbiol. Immunol., 46, 333-342.
20. KOLIOS, G., WRIGHT, K.L., JORDAN, N.J., LEITHEAD, J.B., ROBERTSON, D.A. & WESTWICK, J. (1999). C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur. J. Immunol., 29, 530-536.
21. KOMOROWSKI, J., JANKTEWICZ-WIKA, J., STEPIEN, T., KUZDAK, K. & STEPIEN, H. (2001). Octreotide inhibits the secretion of interleukin-12 from mononuclear cells in human peripheral blood (PBMCs) in vitro. Horm. Metab. Res., 33, 689-690.
22. KOUROUMALIS, E., SKORDILIS, P., THERMOS, K., VASILAKI, A., MOSCHANDREA, J. & MANOUSOS, O.N. (1998). Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut, 42, 442-447.
23. KUBOTA, A., YAMADA, Y., KAGIMOTO, S., SHIMATSU, A., IMAMURA, M., TSUDA, K., IMURA, H., SEINO, S. & SEINO, Y. (1994). Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J. Clin. Invest., 93, 1321-1325.
24. KUSANO, F., TANAKA, Y., MARUMO, F. & SATO, C. (2000). Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab. Invest., 80, 415-422.
25. KUSTERER, K., BUCHHEIT, K.H., SCHADE, A., BRUNS, C., NEUBERGER, C., ENGEL, G. & USADEL, K.H. (1994). The somatostatin analogue octreotide protects against ethanol-induced microcirculatory stasis and elevated vascular permeability in rat gastric mucosa. Eur. J. Pharmacol., 259, 265-271.
26. KUZIEL, W.A., MORGAN, S.J., DAWSON, T.C., GRIFFIN, S., SMITHIES, O., LEY, K. & MAEDA, N. (1997). Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. U.S.A., 94, 12053-12058.
27. LAMBERTS, S.W., VAN DER LELY, A.J., DE HERDER, W.W. & HOFLAND, L.J. (1996). Octreotide. N. Engl. J. Med., 334, 246-254.
28. LAMRANI, A., TULLIEZ, M., CHAUVELOT-MOACHON, L., CHAUSSADE, S., MAUPRIVEZ, C., HAGNERE, A.M. & VIDON, N. (1999). Effects of octreotide treatment on early TNF-alpha production and localization in experimental chronic colitis. Aliment. Pharmacol. Ther., 13, 583-594.
29. LENTSCH, A.B., YOSHIDOME, H., CHEADLE, W.G., MILLER, F.N. & EDWARDS, M.J. (1998). Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology, 27, 1172-1177.
30. LIMBERG, B. & KOMMERELL, B. (1983). Beneficial effect of somatostatin on galactosamine induced liver injury. Regul. Pept., 7, 187-193.
31. LIU, P., MCGUIRE, G.M., FISHER, M.A., FARHOOD, A., SMITH, C.W. & JAESCHKE, H. (1995). Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock, 3, 56-62.
32. MANSY, S.S., YEHIA, H.A., HASSAN, M.M., HASSAN, E.A., YOUSSEF, M.M., HADI, A.A. & MACKENZIE, C.D. (1998). Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis. J. Egypt. Soc. Parasitol., 28, 23-44.
33. MARRA, F. (2002). Chemokines in liver inflammation and fibrosis. Front. Biosci., 7, d1899-d1914.
34. MARRA, F., ROMANELLI, R.G., GIANNINI, C., FAILLI, P., PASTACALDI, S., ARRIGHI, M.C., PINZANI, M., LAFFI, G., MONTALTO, P. & GENTILINI, P. (1999). Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology, 29, 140-148.
35. MCINTOSH, C.H. (1985). Gastrointestinal somatostatin: distribution, secretion and physiological significance. Life Sci., 37, 2043-2058.
36. MEDINA, D.L., TORO, M.J. & SANTISTEBAN, P. (2000). Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin E x cyclin-dependent kinase 2 complexes. J. Biol. Chem., 275, 15549-15556.
37. MOSHER, B., DEAN, R., HARKEMA, J., REMICK, D., PALMA, J. & CROCKETT, E. (2001). Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J. Surg. Res., 99, 201-210.
38. NIEDERMUHLBICHLER, M. & WIEDERMANN, C.J. (1992). Suppression of superoxide release from human monocytes by somatostatin-related peptides. Regul. Pept., 41, 39-47.
39. NOLAN, J.P. (1981). Endotoxin, reticuloendothelial function, and liver injury. Hepatology, 1, 458-465.
40. OOMEN, S.P., VAN HENNIK, P.B., ANTONISSEN, C., LICHTENAUER-KALIGIS, E.G., HOFLAND, L.J., LAMBERTS, S.W., LOWENBERG, B. & TOUW, I.P. (2002). Somatostatin is a selective chemoattractant for primitive (CD34(+)) hematopoietic progenitor cells. Exp. Hematol., 30, 116-125.
41. PAWLIKOWSKI, M., STEPIEN, H., KUNERT-RADEK, J., ZELAZOWSKI, P. & SCHALLY, A.V. (1987). Immunomodulatory action of somatostatin. Ann. N.Y. Acad. Sci., 496, 233-239.
42. PELUSO, G., PETILLO, O., MELONE, M.A., MAZZARELLA, G., RANIERI, M. & TAJANA, G.F. (1996). Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides, 30, 443-451.
43. POLYAK, S.J., KHABAR, K.S., PASCHAL, D.M., EZELLE, H.J., DUVERLIE, G., BARBER, G.N., LEVY, D.E., MUKAIDA, N. & GRETCH, D.R. (2001). Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol., 75, 6095-6106.
44. PROMRAT, K., MCDERMOTT, D.H., GONZALEZ, C.M., KLEINER, D.E., KOZIOL, D.E., LESSIE, M., MERRELL, M., SOZA, A., HELLER, T., GHANY, M., PARK, Y., ALTER, H.J., HOOFNAGLE, J.H., MURPHY, P.M. & LIANG, T.J. (2003). Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology, 124, 352-360.
45. REICHLIN, S. (1983). Somatostatin. N. Engl. J. Med., 309, 1495-1501.
46. REUBI, J.C., WASER, B., MARKUSSE, H.M., KRENNING, E.P., VANHAGEN, M. & LAISSUE, J.A. (1994). Vascular somatostatin receptors in synovium from patients with rheumatoid arthritis. Eur. J. Pharmacol, 271, 371-378.
47. ROLLINS, B.J. (1997). Chemokines. Blood, 90, 909-928.
48. SAKANAKA, C., FERBY, I., WAGA, I., BITO, H. & SHIMIZU, T. (1994). On the mechanism of cytosolic phospholipase A2 activation in CHO cells carrying somatostatin receptor: wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem. Biophys. Res. Commun., 205, 18-23.
49. SALLUSTO, F., MACKAY, C.R. & LANZAVECCHIA, A. (2000). The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol., 18, 593-620.
50. SCHINDLER, M., KIDD, E.J., CARRUTHERS, A.M., WYATT, M.A., JARVIE, E.M., SELLERS, L.A., FENIUK, W. & HUMPHREY, P.P. (1998). Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant. Br. J. Pharmacol., 125, 209-217.
51. SETYONO-HAN, B., HENKELMAN, M.S., FOEKENS, J.A. & KLIJN, G.M. (1987). Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res., 47, 1566-1570.
52. SHERON, N., BIRD, G., KOSKINAS, J., PORTMANN, B., CESKA, M., LINDLEY, I. & WILLIAMS, R. (1993). Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology, 18, 41-46.
53. SHIMODA, K., BEGUM, N.A., SHIBUTA, K., MORI, M., BONKOVSKY, H.L., BANNER, B.F. & BARNARD, G.F. (1998). Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology, 28, 108-115.
54. SU, G.L. (2002). Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. Gastrointest. Liver Physiol., 283, G256-G265.
55. SU, G.L., GOYERT, S.M., FAN, M.H., AMINLARI, A., GONG, K.Q., KLEIN, R.D., MYC, A., ALARCON, W.H., STEINSTRAESSER, L., REMICK, D.G. & WANG, S.C. (2002). Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Am. J. Physiol. Gastrointest. Liver Physiol., 283, G640-G645.
56. TEN BOKUM, A.M., HOFLAND, L.J. & VAN HAGEN, P.M. (2000). Somatostatin and somatostatin receptors in the immune system: a review. Eur. Cytokine Netw., 11, 161-176.
57. TURNER, S.J., DOMIN, J., WATERFIELD, M.D., WARD, S.G. & WESTWICK, J. (1998). The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J. Biol. Chem., 273, 25987-25995.
58. ULEVITCH, R.J. & TOBIAS, P.S. (1995). Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol., 13, 437-457.
59. VALATAS, V., XIDAKIS, C., ROUMPAKI, H., KOLIOS, G. & KOUROUMALIS, E.A. (2003). Isolation of rat Kupffer cells; a combined methodology for highly purified primary cultures. Cell Biol. Int., 27, 67-73.
60. VAN HAGEN, P.M., HOFLAND, L.J., TEN BOKUM, A.M., LICHTENAUER-KALIGIS, E.G., KWEKKEBOOM, D.J., FERONE, D. & LAMBERTS, S.W. (1999). Neuropeptides and their receptors in the immune system. Ann. Med., 31 (Suppl 2), 15-22.
61. WEINSTEIN, S.L., GOLD, M.R. & DEFRANCO, A.L. (1991). Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc. Natl. Acad. Sci. U.S.A., 88, 4148-4152.
62. WIEDERMANN, C.J., REINISCH, N. & BRAUNSTEINER, H. (1993). Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood, 82, 954-960.
63. WINWOOD, P.J. & ARTHUR, M.J. (1993). Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin. Liver Dis., 13, 50-59.
64. YAMAGUCHI, Y., ICHIGUCHI, O., MATSUMURA, F., AKIZUKI, E., MATSUDA, T., OKABE, K., YAMADA, S., LIANG, J., MORI, K. & OGAWA, M. (1997). Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection. Hepatology, 26, 1546-1552.
65. YAMAGUCHI, Y., MATSUMURA, F., TAKEYA, M., ICHIGUCHI, O., KURATSU, J.I., HORIUCHI, T., AKIZUKI, E., MATSUDA, T., OKABE, K., OHSHIRO, H., LIANG, J., MORI, K., YAMADA, S., TAKAHASHI, K. & OGAWA, M. (1998). Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology, 27, 727-734.